IV Levetiracetam Dosing in Children
For acute seizure management in children, administer levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg) as the loading dose, followed by maintenance dosing of 15-30 mg/kg IV every 12 hours (maximum 1,500 mg per dose) depending on the clinical scenario.
Loading Dose for Acute Seizures
The most recent and highest-quality guideline evidence establishes clear weight-based dosing for pediatric patients 1:
- Loading dose: 40 mg/kg IV bolus (maximum 2,500 mg)
- This dose applies to both convulsive and non-convulsive status epilepticus
- Administer as a bolus in addition to any maintenance dose the patient may already be receiving
Maintenance Dosing After Seizure Control
After resolution of status epilepticus, maintenance dosing differs based on seizure type 1:
For non-convulsive status epilepticus:
- 15 mg/kg IV every 12 hours (maximum 1,500 mg per dose)
For convulsive status epilepticus:
- 30 mg/kg IV every 12 hours, OR
- Increase prophylaxis dose by 10 mg/kg (to 20 mg/kg) IV every 12 hours
- Maximum dose: 1,500 mg per dose
Administration Details
The FDA-approved adult formulation provides guidance on infusion parameters 2:
- Administer over 15 minutes as IV infusion
- Do not dilute prior to use (comes in ready-to-use bags)
- For intravenous infusion only
However, pediatric research demonstrates that rapid IV push administration is safe and well-tolerated 3, 4. Studies show:
- Doses of 20-60 mg/kg can be administered rapidly with minimal dilution
- No significant cardiovascular changes or infusion site reactions
- Rapid administration may be preferable in status epilepticus to achieve therapeutic levels quickly
Clinical Context and Evidence Strength
The 2019 Nature Reviews Clinical Oncology guidelines 1 provide the most specific pediatric dosing algorithms, though they were developed for CAR T-cell therapy patients. These recommendations align with broader pediatric epilepsy practice and are supported by multiple research studies demonstrating safety and efficacy in children 5, 6, 4, 7.
Key research findings supporting these doses:
- A prospective study of 30 children using 50 mg/kg loading doses showed excellent tolerability with mean levels of 83.3 mcg/mL 4
- Retrospective analysis of 108 critically ill children using mean loading dose of 28 mg/kg achieved 73% seizure control 5
- High-dose IV levetiracetam (mean 228 mg/kg/day) was well-tolerated in children with intractable epilepsy 6
Important Caveats
Weight-based dosing is critical: The adult guideline evidence 8 uses fixed doses (30 mg/kg in adults, typically 2,500 mg maximum), but pediatric patients require strict weight-based calculation with appropriate maximum doses.
Renal adjustment: While the FDA label 2 provides renal dosing adjustments for adults, pediatric patients with renal impairment require individualized dosing based on creatinine clearance, though specific pediatric renal dosing data are limited.
Monitoring considerations:
- Watch for behavioral changes (agitation, aggression) - reported in 2% of pediatric patients 5
- Mild rash/urticaria possible but rare
- Hypotension risk appears lower than with phenytoin or phenobarbital
- No routine cardiac monitoring required unlike phenytoin
Transition to oral therapy: When switching from IV to oral levetiracetam, use equivalent total daily dose and frequency 2.